Literature DB >> 27211224

Making robust decisions about the impact of health education programs: Psychometric evaluation of the Health Education Impact Questionnaire (heiQ) in diverse patient groups in Norway.

Astrid K Wahl1, Richard H Osborne2, Eva Langeland3, Tore Wentzel-Larsen4, Anne Marit Mengshoel5, Lis Ribu6, Kari Peersen7, Gerald R Elsworth8, Sandra Nolte9.   

Abstract

OBJECTIVE: To undertake a rigorous psychometric evaluation of the widely used eight-scale heiQ version 2.0 (evaluating immediate effects of self-management interventions) in diverse patient groups in Norway.
METHODS: Cross-sectional survey data were collected from 1019 Norwegians. Data were extracted from studies among people with musculoskeletal disorders (n=516), psoriasis (n=254), heart disease (n=97), and Type 2 diabetes (n=152). To investigate the factorial validity of the Norwegian heiQ, confirmatory factor analyses (CFA) were carried out using Mplus.
RESULTS: One-factor model fit, without modifications, was acceptable for the Emotional distress scale. Only one correlated residual was required to be fitted in each of the other scales to achieve satisfactory model fit. The postulated highly restricted full eight-factor model (no cross-loadings, no correlated residuals) showed good fit to the data. Internal consistency was acceptable for most scales (0.72-0.90) but low for Self-monitoring and insight.
CONCLUSION: This study of the Norwegian heiQ replicates the factor structure of the original Australian heiQ, using robust and highly restricted CFA procedures, demonstrating a clean independent clusters model structure. PRACTICE IMPLICATIONS: Researchers, program implementers and policymakers could use the Norwegian heiQ with confidence to generate reliable information on program outcomes and support quality improvement activities.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chronic disease; Confirmatory factor analysis (CFA); Health Education Impact Questionnaire (heiQ); Norway; Self-management

Mesh:

Year:  2016        PMID: 27211224     DOI: 10.1016/j.pec.2016.05.001

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  6 in total

1.  Self-management and health related quality of life in persons with chronic obstructive pulmonary disease.

Authors:  Heidi B Bringsvor; Eva Langeland; Bjørg Frøysland Oftedal; Knut Skaug; Jörg Assmus; Signe Berit Bentsen
Journal:  Qual Life Res       Date:  2019-06-18       Impact factor: 4.147

2.  Validation of the dutch version of the health education impact questionnaire (HEIQ) and comparison of the Dutch translation with the English, German and French HEIQ.

Authors:  Judy W Ammerlaan; Harmieke van Os-Medendorp; Jacob K Sont; Gerald R Elsworth; Richard H Osborne
Journal:  Health Qual Life Outcomes       Date:  2017-01-31       Impact factor: 3.186

3.  Acceptability of an mHealth App Intervention for Persons With Type 2 Diabetes and its Associations With Initial Self-Management: Randomized Controlled Trial.

Authors:  Astrid Torbjørnsen; Milada Cvancarova Småstuen; Anne Karen Jenum; Eirik Årsand; Lis Ribu
Journal:  JMIR Mhealth Uhealth       Date:  2018-05-21       Impact factor: 4.773

4.  Effects of a COPD self-management support intervention: a randomized controlled trial.

Authors:  Heidi B Bringsvor; Eva Langeland; Bjørg Frøysland Oftedal; Knut Skaug; Jörg Assmus; Signe Berit Bentsen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-08

5.  Symptom burden and self-management in persons with chronic obstructive pulmonary disease.

Authors:  Heidi B Bringsvor; Knut Skaug; Eva Langeland; Bjørg Frøysland Oftedal; Jörg Assmus; Doris Gundersen; Richard H Osborne; Signe Berit Bentsen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-24

6.  Evaluation of the Health Education Impact Questionnaire (heiQ), a Self-Management Skill Assessment Tool, in Italian Chronic Patients.

Authors:  Andrea Pozza; Richard H Osborne; Gerald R Elsworth; Giacomo Gualtieri; Fabio Ferretti; Anna Coluccia
Journal:  Psychol Res Behav Manag       Date:  2020-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.